Covered recipient · General Payments record
NANCY SUE WEAVER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2024
$190.71
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $190.71 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $54.41 | 2 |
| Octapharma USA, Inc. | $41.50 | 2 |
| Novo Nordisk AS | $36.57 | 2 |
| Sumitomo Pharma America, Inc. | $29.14 | 2 |
| ABBVIE INC. | $29.09 | 2 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $190.71 | 10 |
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.56 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108387959 | CMS |
| ABBVIE INC. | $13.53 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108387961 | CMS |
| GENZYME CORPORATION | $21.67 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139972041 | CMS |
| GENZYME CORPORATION | $32.74 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139972069 | CMS |
| Novo Nordisk Inc | $21.01 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100327386 | CMS |
| Novo Nordisk Inc | $15.56 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100420367 | CMS |
| Octapharma USA, Inc. | $19.62 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142323990 | CMS |
| Octapharma USA, Inc. | $21.88 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142323992 | CMS |
| Sumitomo Pharma America, Inc. | $14.94 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149002979 | CMS |
| Sumitomo Pharma America, Inc. | $14.20 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149002981 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.